RAPT Therapeutics (RAPT) Capital Expenditures (2020 - 2024)
Historic Capital Expenditures for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $1000.0.
- Therapeutics' Capital Expenditures fell 9850.75% to $1000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $122000.0, marking a year-over-year decrease of 8915.56%. This contributed to the annual value of $122000.0 for FY2024, which is 8915.56% down from last year.
- According to the latest figures from Q4 2024, Therapeutics' Capital Expenditures is $1000.0, which was down 9850.75% from $17000.0 recorded in Q3 2024.
- Over the past 5 years, Therapeutics' Capital Expenditures peaked at $759000.0 during Q1 2023, and registered a low of -$1000.0 during Q2 2024.
- In the last 5 years, Therapeutics' Capital Expenditures had a median value of $98000.0 in 2020 and averaged $170789.5.
- Its Capital Expenditures has fluctuated over the past 5 years, first soared by 78437.5% in 2022, then tumbled by 10042.92% in 2024.
- Over the past 5 years, Therapeutics' Capital Expenditures (Quarter) stood at $174000.0 in 2020, then skyrocketed by 126.44% to $394000.0 in 2021, then tumbled by 87.56% to $49000.0 in 2022, then skyrocketed by 36.73% to $67000.0 in 2023, then plummeted by 98.51% to $1000.0 in 2024.
- Its Capital Expenditures stands at $1000.0 for Q4 2024, versus $17000.0 for Q3 2024 and -$1000.0 for Q2 2024.